Will FDA Platform Technology Designation for HSV-1 Vector Change Krystal Biotech’s (KRYS) Narrative?
Krystal Biotech recently announced that its HSV-1 viral vector, used in KB801 for the treatment of Neurotrophic Keratitis, received FDA...
Technology
Will FDA Platform Technology Designation for HSV-1 Vector Change Krystal Biotech’s (KRYS) Narrative?
Krystal Biotech recently announced that its HSV-1 viral vector, used in KB801 for the treatment of Neurotrophic Keratitis, received FDA...
Krystal Biotech has received a platform technology designation from the FDA for the genetically modified, nonreplicating herpes simplex virus type...
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) announced today that the United States...
All-stock deal will broaden IonQ’s quantum technology portfolio, making it the most complete quantum platform available COLLEGE PARK, Md., September...
Bizarre imagery flooded newsfeeds this week as word spread about a new "pregnancy robot" in development in China. The images...
Sarepta Therapeutics’ platform technology designation from the FDA for the AAVrh74 viral vector it uses in gene therapy products for...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best mid cap growth stocks to invest in now. Earlier on June...
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and...
